Sleep Number Corp: Form 10-Q for the period ended Jul 1, 2023
Filed with the SEC on Aug 8, 2023 and accepted by EDGAR at Aug 8, 2023, 16:13 ET.
Management's discussion and analysis
As filed, 36,324 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Management’s Discussion and Analysis of Financial Condition and Results of Operations (MD&A) is intended to provide a reader of the Company’s condensed consolidated financial statements with a narrative from the perspective of management on its financial condition, results of operations, liquidity and certain other factors that may affect the Company’s future results. MD&A is presented in eight sections:
- Forward-Looking Statements and Risk Factors
- Business Overview
- Results of Operations
- Liquidity and Capital Resources
- Non-GAAP Data Reconciliations
- Off-Balance-Sheet Arrangements and Contractual Obligations
- Critical Accounting Policies
Forward-looking Statements and Risk Factors
The discussion in this Quarterly Report contains certain forward-looking statements that relate to future plans, events, financial results or performance. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “will,” “should,” “could,” “expect,” “anticipate,” “believe,” “estimate,” “plan,” “project,” “predict,” “intend,” “potential,” “continue” or the negative of these or similar terms. These statements are subject to certain risks and uncertainties that could cause actual results to differ materially from the Company’s historical experience and its present expectations or projections. These risks and uncertainties include, among others:
- Current and future economic conditions and consumer sentiment;
- Bank failures or other events affecting financial institutions;
- Increases in interest rates, which have increased the cost of servicing the Company’s indebtedness;
- Availability of attractive and cost-effective consumer credit options;
- Operating with minimal levels of inventory, which may leave the Company vulnerable to supply shortages;
- Sleep Number’s dependence on, and ability to maintain strong working relationships with, key suppliers and third parties;
- Rising commodity costs or third-party logistics costs and other inflationary pressures;
- Risks inherent in global-sourcing activities, including tariffs, geo-political turmoil, war, strikes, labor challenges, government-mandated work closures, outbreaks of pandemics or contagious diseases, and resulting supply shortages and production and delivery delays and disruptions;
- Risks of disruption due to health epidemics or pandemics or COVID-19 variants;
- Regional risks related to having global operations and suppliers, including climate and other disasters;
- The effectiveness of the Company’s marketing strategy and promotional efforts;
- The execution of Sleep Number’s Total Retail distribution strategy;
- Ability to achieve and maintain high levels of product quality;
- Ability to improve and expand Sleep Number’s product line and execute successful new product introductions;
- Ability to prevent third parties from using the Company’s technology or trademarks, and the adequacy of its intellectual property rights to protect its products and brand;
- Ability to compete;
- Risks of disruption in the operation of any of the Company’s main manufacturing, distribution, logistics, home delivery, product development or customer service operations;
- The Company’s ability to comply with existing and changing government regulation;
- Pending or unforeseen litigation and the potential for associated adverse publicity;
- The adequacy of the Company’s and third-party information systems and costs and disruptions related to upgrading or maintaining these systems;
- The Company’s ability to withstand cyber threats that could compromise the security of its systems, result in a data breach or business disruption;
- Sleep Number’s ability, and the ability of its suppliers and vendors, to attract, retain and motivate qualified personnel;
- The volatility of Sleep Number stock;
- Environmental, social and governance (ESG) risks, including increasing regulation and stakeholder expectations; and
- The Company’s ability to adapt to climate change and readiness for legal or regulatory responses thereto.
Additional information concerning these, and other risks and uncertainties is contained under the caption “Risk Factors” in Part I, Item 1A. in the Company’s Annual Report on Form 10-K.
The Company has no obligation to publicly update or revise any of the forward-looking statements contained in this Quarterly Report on Form 10-Q.
Business Overview
Sleep Number is a wellness technology company. It is guided by its purpose to improve the health and wellbeing of society through higher quality sleep; to date, Sleep Number’s innovations have improved over 14.5 million lives. Its wellness technology platform helps solve sleep problems, whether it’s providing individualized temperature control for each sleeper through its Climate360® smart bed or applying its 21 billion hours of longitudinal sleep data and expertise to research with global institutions.
Sleep Number’s smart bed ecosystem drives best-in-class engagement through dynamic, adjustable, and effortless sleep with personalized digital sleep and health insights; its millions of smart sleepers are loyal brand advocates. And Sleep Number’s nearly 5,000 mission-driven team members passionately innovate to drive value creation through its vertically integrated business model, including its exclusive direct-to-consumer selling in 670 stores and online.
Sleep Number generates revenue by marketing and selling its innovations directly to new and existing customers through exclusive, direct-to-consumer retail touch points including Stores, Online, Phone, and Chat (Total Retail). Sleep Number is committed to creating long-term superior value for all stakeholders as it focuses on the Company’s three performance drivers: (1) increasing consumer demand; (2) leveraging its vertically integrated business model; and (3) deploying capital efficiently.
Results of Operations
Quarterly and Year-to-Date Results
Quarterly and year-to-date operating results may fluctuate significantly as a result of a variety of factors, including increases or decreases in sales, timing, amount and effectiveness of advertising expenditures, changes in sales return rates or warranty experience, timing of investments in growth initiatives and infrastructure, timing of store openings/closings and related expenses, changes in net sales resulting from changes in the Company’s store base, timing of new product introductions and related expenses, timing of promotional offerings, competitive factors, changes in commodity costs, disruptions in global supplies or third-party service providers, seasonality of retail and bedding industry sales, consumer sentiment and general economic conditions. The extent to which these external factors will impact the Company’s business and its consolidated financial results will depend on future developments, which are highly uncertain and cannot be predicted. Therefore, the historical results of operations may not be indicative of the results that may be achieved for any future period.
Highlights
Financial highlights for the three months ended July 1, 2023 were as follows:
- Net sales for the three months ended July 1, 2023 of $459 million decreased from $549 million for the same period one year ago. Demand was impacted by historically low consumer sentiment. Prior-year net sales benefited from the delivery of high-revenue smart beds from backlog due to delayed supply of semiconductor chips.
- The net sales change consisted of a 18% comparable sales decrease in Total Retail offset by additional sales from 13 net new stores opened in the past 12 months that added 2 percentage points (ppt.) of growth. For additional details, see the components of total net sales change on page 16.
- Sales per store (sales for stores open at least one year, Total Retail, including online, phone and chat) on a trailing twelve-month basis for the period ended July 1, 2023 totaled $3.1 million, compared with $3.5 million for the same period last year.
- Operating income for the three months ended July 1, 2023 was $11 million, compared with $50 million in the prior-year period. The $39 million decrease in operating income was driven by the lower net sales and a 1.6 ppt. decrease in the gross profit rate offset by a $22 million reduction in operating expenses.
- The 1.6 ppt. gross profit rate decrease was primarily due to prior year’s delivery of high-revenue smart beds and bases, partially offset by pricing actions taken over the past twelve months. See the Gross profit discussion on page 18 for additional details.
- The $22 million reduction in the Company’s operating expenses was mainly due to lower marketing expenses.
- Net income for the three months ended July 1, 2023 decreased to $1 million, compared with $35 million for the same period one year ago. Net income per diluted share was $0.03, compared with $1.54 last year.
- The Company achieved an adjusted return on invested capital (Adjusted ROIC) of 12.3% on a trailing twelve-month basis for the period ended July 1, 2023, compared with 34.9% for the comparable period one year ago.
- The Company generated $19 million in cash from operating activities for the six months ended July 1, 2023, compared with $29 million for the same period one year ago.
- As of July 1, 2023, the Company had $484 million of borrowings under its revolving credit facility and available net liquidity of $334 million.
The following table sets forth the Company’s results of operations expressed as dollars and percentages of net sales. Figures are in millions, except percentages and per share amounts. Amounts may not add due to rounding differences.
| Three Months Ended July 1, 2023 | July 2, 2022 | Six Months Ended July 1, 2023 | July 2, 2022 | |||||
|---|---|---|---|---|---|---|---|---|
| Net sales | $458.8 | 100.0% | $549.1 | 100.0% | $985.3 | 100.0% | $1,076.2 | 100.0% |
| Cost of sales | 194.5 | 42.4% | 224.1 | 40.8% | 410.8 | 41.7% | 449.0 | 41.7% |
| Gross profit | 264.2 | 57.6% | 324.9 | 59.2% | 574.5 | 58.3% | 627.2 | 58.3% |
| Operating expenses: | ||||||||
| Sales and marketing | 197.8 | 43.1% | 220.5 | 40.2% | 428.3 | 43.5% | 460.7 | 42.8% |
| General and administrative | 39.8 | 8.7% | 38.7 | 7.1% | 79.2 | 8.0% | 80.0 | 7.4% |
| Research and development | 15.4 | 3.4% | 15.8 | 2.9% | 29.9 | 3.0% | 32.1 | 3.0% |
| Total operating expenses | 253.0 | 55.1% | 275.0 | 50.1% | 537.4 | 54.5% | 572.9 | 53.2% |
| Operating income | 11.2 | 2.4% | 49.9 | 9.1% | 37.2 | 3.8% | 54.3 | 5.0% |
| Interest expense, net | 9.9 | 2.2% | 3.6 | 0.7% | 19.1 | 1.9% | 5.7 | 0.5% |
| Income before income taxes | 1.3 | 0.3% | 46.3 | 8.4% | 18.1 | 1.8% | 48.6 | 4.5% |
| Income tax expense | 0.5 | 0.1% | 11.4 | 2.1% | 5.9 | 0.6% | 11.6 | 1.1% |
| Net income | $0.8 | 0.2% | $34.9 | 6.4% | $12.2 | 1.2% | $37.0 | 3.4% |
| Net income per share: | ||||||||
| Basic | $0.03 | $1.56 | $0.55 | $1.64 | ||||
| Diluted | $0.03 | $1.54 | $0.54 | $1.60 | ||||
| Weighted-average number of common shares: | ||||||||
| Basic | 22.5 | 22.4 | 22.4 | 22.6 | ||||
| Diluted | 22.5 | 22.7 | 22.5 | 23.2 |
The percentage of total net sales, by dollar volume, was as follows:
| Three Months Ended July 1, 2023 | July 2, 2022 | Six Months Ended July 1, 2023 | July 2, 2022 | |
|---|---|---|---|---|
| Retail stores | 87.7% | 89.4% | 87.4% | 86.9% |
| Online, phone, chat and other | 12.3% | 10.6% | 12.6% | 13.1% |
| Total Company | 100.0% | 100.0% | 100.0% | 100.0% |
The components of total net sales change, including comparable net sales changes, were as follows:
| Sales change rates: | Three Months Ended July 1, 2023 | July 2, 2022 | Six Months Ended July 1, 2023 | July 2, 2022 |
|---|---|---|---|---|
| Retail comparable-store sales (1) | (20%) | 10% | (10%) | (3%) |
| Online, phone and chat | (3%) | 2% | (12%) | 4% |
| Total Retail comparable sales change (1) | (18%) | 9% | (10%) | (2%) |
| Net opened/closed stores and other | 2% | 4% | 2% | 4% |
| Total Company | (16%) | 13% | (8%) | 2% |
(1) Stores are included in the comparable-store calculations in the 13th full month of operations. Stores that have been remodeled or repositioned within the same shopping center remain in the comparable-store base.
Other sales metrics were as follows:
| Three Months Ended July 1, 2023 | July 2, 2022 | Six Months Ended July 1, 2023 | July 2, 2022 | |
|---|---|---|---|---|
| Average sales per store (1) (in thousands) | $3,089 | $3,526 | ||
| Average sales per square foot (1) | $1,007 | $1,172 | ||
| Stores > $2 million in net sales (2) | 71% | 82% | ||
| Stores > $3 million in net sales (2) | 31% | 45% | ||
| Average revenue per smart bed unit (3) | $5,990 | $6,485 | $5,913 | $5,601 |
(1) Trailing-twelve months Total Retail comparable sales per store open at least one year.
(2) Trailing-twelve months for stores open at least one year (excludes online, phone and chat sales).
(3) Represents Total Retail net sales divided by Total Retail smart bed units.
The number of retail stores operating was as follows:
| Three Months Ended July 1, 2023 | July 2, 2022 | Six Months Ended July 1, 2023 | July 2, 2022 | |
|---|---|---|---|---|
| Beginning of period | 671 | 653 | 670 | 648 |
| Opened | 7 | 10 | 19 | 23 |
| Closed | (6) | (4) | (17) | (12) |
| End of period | 672 | 659 | 672 | 659 |
17 | 2Q 2023 FORM 10-Q SLEEP NUMBER CORPORATION
Comparison of Three Months Ended July 1, 2023 with Three Months Ended July 2, 2022
Net sales
Net sales for the three months ended July 1, 2023 of $459 million decreased from $549 million for the same period one year ago. Demand was impacted by historically low consumer sentiment. Prior-year net sales benefited from the delivery of high-revenue smart beds from backlog due to delayed supply of semiconductor chips.
The net sales change consisted primarily of a 18% comparable sales decrease in Total Retail offset by additional sales from 13 net new stores opened in the past 12 months that added 2 percentage points (ppt.) of growth.
The $90.3 million net sales decrease compared with the same period one year ago was comprised of the following: (i) a $92.8 million decrease in Retail comparable net sales; (ii) a $1.6 million decrease from phone, online and other sales; offset by (iii) a $4.1 million increase from net store openings. Total Retail smart bed unit sales decreased 10% compared with the prior year. Total Retail average revenue per smart bed unit decreased by 8% to $5,990, compared with $6,485 in the prior-year period. Prior year average revenue per smart bed unit benefited from the delivery of high-revenue smart beds from backlog due to delayed supply of semiconductor chips.
Gross profit
Gross profit of $264 million for the three months ended July 1, 2023 decreased by $61 million, or 19%, compared with $325 million for the same period one year ago. The gross profit rate decreased to 57.6% of net sales for the three months ended July 1, 2023, compared with 59.2% for the prior-year comparable period.
The current-year gross profit rate decrease of 1.6 ppt. was mainly due to: (i) prior year’s delivery of high-revenue smart beds and bases pressured the rate by 2.4 ppt.; (ii) higher returns and warranty costs, primarily related to the returnability of the integrated adjustable base as part of the Climate360 smart bed, impacted the rate by 0.6 ppt.; (iii) increased company-wide performance-based incentive compensation impacted the rate by 0.3 ppt.; (iv) lower delivered smart bed volume deleveraged the rate by 0.2 ppt.; partially offset by (v) favorable pricing actions taken over the past twelve months, increased the rate by 1.6 ppt.; and (vi) improvement in commodity prices and operating efficiencies improved the rate by 0.2 ppt. In addition, the gross profit rate may fluctuate from quarter to quarter due to a variety of other factors, including changes in manufacturing and supply chain operations and performance-based incentive compensation.
Sales and marketing expenses
Sales and marketing expenses for the three months ended July 1, 2023 were $198 million, or 43.1% of net sales, compared with $220 million, or 40.2% of net sales, for the same period one year ago. The current-year sales and marketing expenses rate increase of 2.9 ppt. was primarily due to the deleveraging impact of 16% lower net sales partially offset by a 25% decrease in consumer financing costs as the Company adjusted promotional offers to mitigate increased costs associated with the higher interest rate environment. Media spend was 12% lower year-over-year.
General and administrative expenses
General and administrative (G&A) expenses totaled $40 million, or 8.7% of net sales, for the three months ended July 1, 2023, compared with $39 million, or 7.1% of net sales, in the prior-year period. The $1.1 million increase in G&A expenses consisted mainly of: (i) a $3.6 million increase in company-wide performance-based incentive compensation; (ii) a $0.8 million increase in technology expenses; offset by (iii) a $3.5 million reduction in employee compensation on lower headcount. The G&A expenses rate increased by 1.6 ppt. in the current-year period, compared with the same period one year ago due to the items discussed above and the deleveraging impact of lower net sales.
Research and development expenses
Research and development (R&D) expenses decreased to $15 million for the three months ended July 1, 2023, compared with $16 million with the same period last year on lower headcount. The Company continues to maintain a flexible mindset, to capitalize on profitable opportunities as the environment improves, and deliver tangible life-changing health benefits for Smart Sleepers.
Interest expense, net
Interest expense, net increased to $10 million for the three months ended July 1, 2023, compared with $4 million for the same period one year ago. The $6 million increase was mainly driven by a higher weighted-average interest rate compared with the same period one year ago.
Income tax expense
Income tax expense totaled $0.5 million for the three months ended July 1, 2023, compared with $11.4 million last year. The effective income tax rate for the three months ended July 1, 2023 was 41.0%, compared with 24.5% for the comparable period last year. Discrete tax expenses, primarily stock-based compensation excess tax expense, was $0.1 million for the three months ended July 1, 2023, compared with discrete tax benefits of $0.1 million in last year’s second quarter.
Comparison of Six Months Ended July 1, 2023 with Six Months Ended July 2, 2022
Net sales
Net sales for the six months ended July 1, 2023 decreased by $91 million, or 8%, to $985 million, compared with $1.08 billion for the same period one year ago. Demand was impacted by historically low consumer sentiment.
The 8% net sales decrease consisted of a 10% comparable sales decrease in Total Retail, partially offset by 2 percentage points (ppt.) of sales growth from net new stores opened in the past 12 months. For additional details, see the components of total net sales change on page 16.
The $91 million net sales decrease compared with the same period one year ago was comprised of the following: (i) a $89 million decrease in Retail comparable net sales; (ii) a $16 million decrease in online, phone and other sales; partially offset by (iii) a $14 million increase resulting from net store openings. Total smart bed unit sales declined 13% compared with the prior year. Average revenue per smart bed unit in Total Retail increased by 6% to $5,913, compared with $5,601 in the prior-year period.
Gross profit
Gross profit of $575 million decreased by $53 million, or 8%, compared with $627 million for the same period one year ago. The gross profit rate was 58.3% of net sales for the six months ended July 1, 2023, consistent with the prior-year comparable period.
The current-year gross profit rate of 58.3% remained consistent with the same period one year ago: (i) favorable pricing actions taken over the past twelve months increased the rate by 1.6 ppt.; (ii) improvement in commodity prices and operating efficiencies increased the rate by 0.4 ppt.; offset by (iii) higher mix of high-end adjustable bases last year due to semiconductor chip supply constraints limiting the Company’s product availability pressured the rate by 0.7 ppt.; (iv) higher returns and warranty costs, primarily related to the returnability of the integrated adjustable base as part of the Climate360 smart bed, decreased the rate by 0.6 ppt.; (v) increased company-wide performance-based incentive compensation decreased the rate by 0.3 ppt.; (vi) lower delivered smart bed volume deleveraged the rate by 0.3 ppt.; and (vii) incremental logistics and delivery costs, including labor inflation and investments in our distribution network, decreased the rate by 0.2 ppt. The gross profit rate may fluctuate from quarter to quarter due to a variety of other factors, including changes in manufacturing and supply chain operations and performance-based incentive compensation.
Sales and marketing expenses
Sales and marketing expenses for the six months ended July 1, 2023 were $428 million, or 43.5% of net sales, compared with $461 million, or 42.8% of net sales, for the same period one year ago. The current-year sales and marketing expenses rate increase of 0.7 ppt. was primarily due to: (i) deleveraging impact of a 8% sales decline; (ii) the additional costs associated with operating 13 net new stores; partially offset by (iv) a 12% decrease in media spend year-over-year resulting in 0.5 ppt. of leverage.
General and administrative expenses
General and administrative (G&A) expenses totaled $79 million, or 8.0% of net sales, for the six months ended July 1, 2023, compared with $80 million, or 7.4% of net sales, in the prior-year period. The $1 million decrease in G&A expenses consisted of: (i) a $5.9 million reduction in employee compensation on lower headcount; (ii) a $1.7 million decrease in professional and consulting fees; (iii) a $0.5 million decrease in travel and training expenses; and (iv) a $1.4 million decrease in other miscellaneous expenses; partially offset by (v) a $7.0 million increase in company-wide, performance-based incentive compensation; and (vi) a $1.7 million increase in technology investments. The G&A expenses rate increased by 0.6 ppt. in the current-year period, compared with the same period one year ago due to the deleveraging impact of the 8% net sales decrease partially offset by the net expense reductions discussed above.
Research and development expenses
Research and development (R&D) expenses decreased by 7% to $30 million for the six months ended July 1, 2023, compared with $32 million for the same period one year ago. The Company continues to maintain a flexible mindset, to capitalize on profitable opportunities as the environment improves, and deliver tangible life-changing health benefits for Smart Sleepers.
Interest expense, net
Interest expense, net increased to $19 million for the six months ended July 1, 2023, compared with $6 million for the same period one year ago. The $13 million increase was mainly driven by a higher weighted-average interest rate compared with the same period one year ago.
Income tax expense
Income tax expense totaled $6 million for the six months ended July 1, 2023, compared with $12 million last year. The effective income tax rate for the six months ended July 1, 2023 increased to 32.5%, compared with 23.8% for the comparable period last year, reflecting higher discrete tax expenses, primarily stock-based compensation excess tax expense in the current-year six-month period of $1.1 million versus the prior-year, six-month period of $0.6 million.
Liquidity and Capital Resources
Managing liquidity and capital resources is an important part of the Company’s commitment to deliver superior shareholder value over time. The Company’s primary sources of liquidity are cash flows provided by operating activities and cash available under its $825 million revolving credit facility. As of July 1, 2023, the Company does not have any off-balance sheet financing other than its $7 million in outstanding letters of credit. The cash generated from ongoing operations and cash available under the revolving credit facility are expected to be adequate to maintain operations, and fund anticipated expansion, strategic initiatives and contractual obligations such as lease payments and capital commitments for new retail stores for the foreseeable future.
Changes in cash and cash equivalents during the six months ended July 1, 2023 primarily consisted of $19 million of cash provided by operating activities and an $15 million increase in short-term borrowings, offset by $30 million of cash used to purchase property and equipment and $4 million of cash used to repurchase its common stock (based on settlement, in connection with the vesting of employee restricted stock grants).
The following table summarizes cash flows (in millions). Amounts may not add due to rounding differences:
| Total cash provided by (used in): | Six Months Ended July 1, 2023 | July 2, 2022 |
|---|---|---|
| Operating activities | $18.7 | $28.7 |
| Investing activities | (30.3) | (36.5) |
| Financing activities | 11.6 | 7.7 |
| Net increase (decrease) in cash and cash equivalents | $0.0 | $(0.1) |
20 | 2Q 2023 FORM 10-Q SLEEP NUMBER CORPORATION
Cash provided by operating activities for the six months ended July 1, 2023 was $19 million, compared with $29 million for the six months ended July 2, 2022. Significant components of the year-over-year change in cash provided by operating activities included: (i) a $25 million decrease in net income for the six months ended July 1, 2023, compared with the same period one year ago; (ii) a $25 million fluctuation in accrued compensation and benefits primarily related to year-over-year changes in company-wide performance-based compensation that was earned in 2021 and paid in the first quarter of 2022, compared with no company-wide performance-based compensation earned in 2022 and paid in the first quarter of 2023; and (iv) a $12 million fluctuation in prepaid expenses and other assets primarily due to the amount and timing of rebate payments.
Net cash used in investing activities to purchase property and equipment was $30 million for the six months ended July 1, 2023, compared with $37 million for the same period one year ago. The year-over-year decrease was primarily due to the timing of cash flows associated with investments in information technology.
Net cash provided by financing activities was $12 million for the six months ended July 1, 2023, compared with $8 million for the same period last year. During the six months ended July 1, 2023, the Company repurchased $4 million of its stock (based on settlement dates, in connection with the vesting of employee restricted stock awards), compared with $64 million (based on settlement dates, $55 million under the Board-approved share repurchase program and $9 million in connection with the vesting of employee restricted stock awards) during the same period one year ago. Short-term borrowings increased by $15 million during the current-year period due to a $24 million increase in borrowings under the revolving credit facility to $484 million offset by a $9 million decrease in book overdrafts which are included in the net change in short-term borrowings. Short-term borrowings increased by $71 million during the prior-year period due to a $61 million increase in borrowings under the credit facility to $443 million and a $10 million increase in book overdrafts.
In the second quarter of fiscal 2022, the Company suspended share repurchases under its Board-approved share repurchase program. At July 1, 2023, there was $348 million remaining authorization under the Board-approved $600 million share repurchase program. There is no expiration date governing the period over which the Company can repurchase shares.
The Company has a credit facility (Credit Agreement) which is for general corporate purposes, to meet its seasonal working capital requirements and to repurchase its stock. The Company amended the Credit Agreement on October 26, 2022. The amendment, among other things, (a) provides relief from the requirement that the net leverage ratio not exceed 3.75x for certain corporate actions including Permitted Capital Distributions for Performance or Taxes (as defined in the Credit Agreement) and certain acquisition activity; (b) increases the permissible net leverage ratio to 5.0x for the three consecutive quarterly reporting periods ending July 1, 2023; (c) increases the commitment fee rate to 50 basis points and the margin applicable to interest rates for all borrowings by an additional 50 basis points, in each case if the net leverage ratio is greater than or equal to 4.5x; and (d) replaces the option to borrow at an interest rate based on London Interbank Offered Rate (LIBOR) to one based on a Term SOFR Rate. The Term SOFR Rate equals the sum of (x) the Term SOFR Screen Rate (as defined in the Credit Agreement) for the applicable interest period (but in no event less than zero), plus (y) 0.10%, plus (z) the margin based on Sleep Number’s net leverage ratio. Under the terms of the Credit agreement, the Company pays a variable rate of interest and a commitment fee based on its leverage ratio.
The Company amended the Credit Agreement on July 24, 2023. The amendment, among other things, extends the increased permissible net leverage ratio to 5.0x to include the quarterly reporting period ending September 30, 2023.
At July 1, 2023, the Company had $484 million of borrowings under its revolving credit facility, $7 million in outstanding letters of credit and net liquidity available under the credit facility of $334 million. At July 1, 2023, the Company’s leverage ratio as defined in the credit agreement was 4.7x, the weighted-average interest rate on borrowings under the credit facility was 7.5% and the Company was in compliance with all financial covenants.
Sleep Number has an agreement with Synchrony Bank to offer qualified customers revolving credit arrangements to finance their purchases from the Company (Synchrony Agreement). The Synchrony Agreement contains financial covenants consistent with the credit facility, including a maximum net leverage ratio and a minimum interest coverage ratio. As of July 1, 2023, the Company was in compliance with all financial covenants.
Non-GAAP Data Reconciliations
Earnings before Interest, Taxes, Depreciation and Amortization (Adjusted EBITDA)
The Company defines earnings before interest, taxes, depreciation and amortization (Adjusted EBITDA) as net income plus: income tax expense, interest expense, depreciation and amortization, stock-based compensation and asset impairments. Management believes Adjusted EBITDA is a useful indicator of its financial performance and its ability to generate cash from operating activities. The Company’s definition of Adjusted EBITDA may not be comparable to similarly titled definitions used by other companies. The table below reconciles Adjusted EBITDA, which is a non-GAAP financial measure, to the comparable GAAP financial measure.
Adjusted EBITDA calculations are as follows (in thousands):
| Three Months Ended July 1, 2023 | July 2, 2022 | Trailing-Twelve Months Ended July 1, 2023 | July 2, 2022 | |
|---|---|---|---|---|
| Net income | $754 | $34,933 | $11,822 | $101,869 |
| Income tax expense | 524 | 11,359 | 6,602 | 30,442 |
| Interest expense | 9,948 | 3,619 | 32,289 | 9,406 |
| Depreciation and amortization | 18,304 | 15,920 | 71,318 | 61,857 |
| Stock-based compensation | 5,252 | 3,910 | 15,071 | 18,872 |
| Asset impairments | 170 | 80 | 294 | 266 |
| Adjusted EBITDA | $34,952 | $69,821 | $137,396 | $222,712 |
Free Cash Flow
The Company’s “free cash flow” data is considered a non-GAAP financial measure and is not in accordance with, or preferable to, “net cash provided by operating activities,” or GAAP financial data. However, the Company is providing this information as it believes it facilitates analysis for investors and financial analysts.
The following table summarizes free cash flow calculations (in thousands):
| Six Months Ended July 1, 2023 | July 2, 2022 | Trailing-Twelve Months Ended July 1, 2023 | July 2, 2022 | |
|---|---|---|---|---|
| Net cash provided by operating activities | $18,720 | $28,691 | $26,167 | $167,281 |
| Subtract: Purchases of property and equipment | 29,899 | 36,559 | 62,794 | 71,447 |
| Free cash flow | $(11,179) | $(7,868) | $(36,627) | $95,834 |
22 | 2Q 2023 FORM 10-Q SLEEP NUMBER CORPORATION
Non-GAAP Data Reconciliations (continued)
Return on Invested Capital (Adjusted ROIC)
(dollars in thousands)
Adjusted ROIC is a financial measure the Company uses to determine how efficiently it deploys its capital. It quantifies the return the Company earns on its adjusted invested capital. Management believes Adjusted ROIC is also a useful metric for investors and financial analysts. The Company computes Adjusted ROIC as outlined below. Its definition and calculation of Adjusted ROIC may not be comparable to similarly titled definitions and calculations used by other companies.
The tables below reconcile adjusted net operating profit after taxes (Adjusted NOPAT) and total adjusted invested capital, which are non-GAAP financial measures, to the comparable GAAP financial measures (in thousands):
| Adjusted net operating profit after taxes (Adjusted NOPAT) | Trailing-Twelve Months Ended July 1, 2023 | July 2, 2022 |
|---|---|---|
| Operating income | $50,713 | $141,718 |
| Add: Operating lease expense (1) | 27,040 | 25,079 |
| Less: Income taxes (2) | (21,993) | (39,798) |
| Adjusted NOPAT | $55,760 | $126,999 |
| Average adjusted invested capital | ||
| Total deficit | $(419,141) | $(442,962) |
| Add: Long-term debt (3) | 484,161 | 443,779 |
| Add: Operating lease obligations (4) | 438,483 | 420,516 |
| Total adjusted invested capital at end of period | $503,503 | $421,333 |
| Average adjusted invested capital (5) | $452,573 | $363,986 |
| Adjusted return on invested capital (Adjusted ROIC) (6) | 12.3% | 34.9% |
(1) Represents the interest expense component of lease expense included in the Company’s financial statements under ASC 842, Leases.
(2) Reflects annual effective income tax rates, before discrete adjustments, of 28.3% and 23.9% for July 1, 2023 and July 2, 2022, respectively.
(3) Long-term debt includes existing finance lease liabilities.
(4) Reflects operating lease liabilities included in the Company’s financial statements under ASC 842.
(5) Average adjusted invested capital represents the average of the last five fiscal quarters’ ending adjusted invested capital balances.
(6) Adjusted ROIC equals Adjusted NOPAT divided by average adjusted invested capital.
Note - the Company’s ROIC calculation and data are considered non-GAAP financial measures and are not in accordance with, or preferable to, GAAP financial data. However, the Company is providing this information as it believe it facilitates analysis of the Company's financial performance by investors and financial analysts. The Company updated its Adjusted ROIC calculation effective beginning with the reporting period ended December 31, 2022, to reflect adjustments consistent with ASC 842. The prior period has been updated to reflect this calculation.
GAAP - generally accepted accounting principles in the U.S.
Critical Accounting Policies
The Company discusses its critical accounting policies and estimates in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2022. There were no significant changes in the Company’s critical accounting policies since the end of fiscal 2022.
Market risk
As filed, 470 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The Company is exposed to changes in market-based short-term interest rates that will impact net interest expense. If overall interest rates were one percentage point higher than current rates, annual net income would decrease by $3.5 million based on the $484 million of borrowings under the credit facility at July 1, 2023. The Company does not manage the interest-rate volatility risk of borrowings under the credit facility through the use of derivative instruments.
Controls and procedures
As filed, 1,591 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Conclusions Regarding the Effectiveness of Disclosure Controls and Procedures
The Company maintains disclosure controls and procedures, as defined in Exchange Act Rule 13a-15(e), that are designed to ensure that information required to be disclosed by the Company in the reports that it files or submits under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to the Company’s management, including its principal executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. The Company’s management, with the participation of its principal executive officer and principal financial officer, evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures as of the end of the period covered by this quarterly report. Based on this evaluation, its principal executive officer and principal financial officer concluded that the Company’s disclosure controls and procedures were effective as of the end of the period covered by this quarterly report.
Changes in Internal Control
There were no changes in the Company’s internal control over financial reporting during the fiscal quarter ended July 1, 2023, that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
Risk factors
As filed, 2,624 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
In addition to the risks discussed below and other information set forth in this Quarterly Report on Form 10-Q, the Company’s business, financial condition and operating results are subject to a number of risks and uncertainties, including both those that are specific to the Company’s business and others that affect all businesses operating in a global environment. Investors should carefully consider the information in this report under the heading, Management’s Discussion and Analysis of Financial Condition and Results of Operations, and also the information under the heading, Risk Factors, in the Company’s most recent Annual Report on Form 10-K. The risk factors discussed in the Annual Report on Form 10-K and in this Quarterly Report on Form 10-Q do not identify all risks that the Company faces because its business operations could also be affected by additional risk factors that are not presently known to the Company or that it currently considers to be immaterial to its operations.
Bank failures or other events affecting financial institutions could adversely affect our liquidity and financial performance.
The recent and potential future disruptions in access to bank deposits or lending commitments due to bank failures and banking industry instability could materially and adversely affect the Company’s liquidity, access to cash and credit, and the Company’s business, financial condition and results of operations, as well those of the Company’s third-party suppliers or vendors. The recent closures of Silicon Valley Bank (SVB) and Signature Bank and their placement into receivership with the Federal Deposit Insurance Company (FDIC) along with the FDIC’s seizure and sale of First Republic Bank created market disruption and uncertainty with respect to the financial condition of a number of other banking institutions in the United States. While the Company does not have any direct exposure to SVB, Signature Bank, or First Republic Bank, the Company does maintain its cash at financial institutions, occasionally in balances that exceed the current FDIC insurance limits.
If other banks and financial institutions enter receivership or become insolvent in the future due to financial conditions affecting the banking system and financial markets, the Company’s ability to access its cash and cash equivalents, including transferring funds, making payments or receiving funds, and the Company’s access to credit, as well as those of its third-party suppliers or vendors, may be threatened and could have a material adverse effect on the Company’s business and financial condition.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-07-01. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-04-02 to 2023-07-01 | $458.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2023-01-01 to 2023-07-01 | $985.3m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-04-02 to 2023-07-01 | $194.5m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2023-01-01 to 2023-07-01 | $410.8m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2023-04-02 to 2023-07-01 | $264.2m | us-gaap:GrossProfit |
| Gross profit | 6 months2023-01-01 to 2023-07-01 | $574.5m | us-gaap:GrossProfit |
| Research and development | 3 months2023-04-02 to 2023-07-01 | $15.4m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2023-01-01 to 2023-07-01 | $29.9m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2023-04-02 to 2023-07-01 | $11.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2023-01-01 to 2023-07-01 | $37.2m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2023-04-02 to 2023-07-01 | $524.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2023-01-01 to 2023-07-01 | $5.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-04-02 to 2023-07-01 | $754.0k | us-gaap:NetIncomeLoss |
| Net income | 6 months2023-01-01 to 2023-07-01 | $12.2m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-04-02 to 2023-07-01 | $0.03 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2023-01-01 to 2023-07-01 | $0.54 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-04-02 to 2023-07-01 | $0.03 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2023-01-01 to 2023-07-01 | $0.55 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-04-02 to 2023-07-01 | 22,502,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2023-01-01 to 2023-07-01 | 22,543,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2023-01-01 to 2023-07-01 | $18.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2023-01-01 to 2023-07-01 | $29.9m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 6 months2023-01-01 to 2023-07-01 | $3.5m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-07-01 | $1.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-07-01 | $208.5m | us-gaap:AssetsCurrent |
| Total assets | At period end2023-07-01 | $965.2m | us-gaap:Assets |
| Current liabilities | At period end2023-07-01 | $921.8m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-07-01 | $1.38bn | us-gaap:Liabilities |
| Current portion of debt | At period end2023-07-01 | $483.8m | us-gaap:DebtCurrent |
| Shareholders' equity | At period end2023-07-01 | −$419.1m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2023-07-01 | 22,214,000 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000827187-23-000081. Last ingested by Listed: Oct 24, 2026, 14:57 ET. Listed shows no prices and gives no investment advice.